The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126143341 12614334 1 I 2016 20160217 20160802 20160802 PER US-JAZZ-2016-US-003050 JAZZ 59.39 YR F Y 0.00000 20160802 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126143341 12614334 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID 21196 2.25 G ORAL SOLUTION
126143341 12614334 2 SS RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 UNK Y 0 TABLET
126143341 12614334 3 C PROVIGIL MODAFINIL 1 UNK U 0 TABLET
126143341 12614334 4 C PREVACID LANSOPRAZOLE 1 UNK U 0 CAPSULE
126143341 12614334 5 C Aspirin ec ASPIRIN 1 UNK U 0 TABLET
126143341 12614334 6 C Biotin BIOTIN 1 UNK U 0 CAPSULE
126143341 12614334 7 C CLINDAMYCIN CLINDAMYCINCLINDAMYCIN PHOSPHATE 1 Vaginal UNK U 0 CREAM
126143341 12614334 8 C COENZYME Q10 UBIDECARENONE 1 GUMMIES U 0
126143341 12614334 9 C ESTRACE ESTRADIOL 1 UNK U 0 CREAM
126143341 12614334 10 C FLAGYL METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE 1 UNK U 0 TABLET
126143341 12614334 11 C LUNESTA ESZOPICLONE 1 UNK U 0 TABLET
126143341 12614334 12 C MAGNESIUM OXIDE. MAGNESIUM OXIDE 1 UNK U 0 TABLET
126143341 12614334 13 C NASONEX MOMETASONE FUROATE 1 NASAL SPRAY U 0 NASAL SPRAY
126143341 12614334 14 C PROPRANOLOL PROPRANOLOLPROPRANOLOL HYDROCHLORIDE 1 UNK U 0 TABLET
126143341 12614334 15 C VITAMIN D3 CHOLECALCIFEROL 1 UNK U 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126143341 12614334 1 Narcolepsy
126143341 12614334 2 Product used for unknown indication
126143341 12614334 3 Product used for unknown indication
126143341 12614334 4 Product used for unknown indication
126143341 12614334 5 Product used for unknown indication
126143341 12614334 6 Product used for unknown indication
126143341 12614334 7 Product used for unknown indication
126143341 12614334 8 Product used for unknown indication
126143341 12614334 9 Product used for unknown indication
126143341 12614334 10 Product used for unknown indication
126143341 12614334 11 Product used for unknown indication
126143341 12614334 12 Product used for unknown indication
126143341 12614334 13 Product used for unknown indication
126143341 12614334 14 Product used for unknown indication
126143341 12614334 15 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
126143341 12614334 Feeling abnormal
126143341 12614334 Flushing
126143341 12614334 Headache
126143341 12614334 Memory impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126143341 12614334 1 20160213 0
126143341 12614334 3 2010 20160212 0
126143341 12614334 10 20160212 0
126143341 12614334 11 20160212 0